US Patent:
20130315901, Nov 28, 2013
Inventors:
Frederick J. Derosier - Research Triangle Park, NC, US
Immanuel Freedman - King of Prussia PA, US
Ole Graff - Research Triangle Park NC, US
Richard A. Grove - Uxbridge, GB
Assignee:
Glaxo Group Limited - Greenford, Middlesex
International Classification:
A61K 39/395
US Classification:
4241331, 4241721, 4241421
Abstract:
A method of treating, arresting or preventing a disease responsive to treatment with an anti-CD20 antibody in a patient suffering therefrom, comprising administering to the patient at least one sub-depleting dose of antiCD20 antibody is disclosed.